Raymond C. Kubacki's most recent trade in Psychemedics Corp. was a trade of 1,500 Common Stock, $.005 Par Value done at an average price of $4.9 . Disclosure was reported to the exchange on May 22, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.93 per share. | 22 May 2023 | 1,500 | 246,737 (4%) | 0% | 4.9 | 7,395 | Common Stock, $.005 Par Value |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.87 per share. | 15 May 2023 | 1,725 | 248,237 (4%) | 0% | 4.9 | 8,401 | Common Stock, $.005 Par Value |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.18 per share. | 11 Nov 2022 | 2,625 | 249,962 (4%) | 0% | 6.2 | 16,223 | Common Stock, $.005 Par Value |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2022 | 20,000 | 252,587 (4%) | 0% | 0 | Common Stock, $.005 Par Value | |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. | 13 May 2022 | 1,725 | 232,587 (4%) | 0% | 6.4 | 11,109 | Common Stock, $.005 Par Value |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.50 per share. | 12 Nov 2021 | 3,062 | 234,312 (4%) | 0% | 8.5 | 26,027 | Common Stock, $.005 Par Value |
| Psychemedics Corp | Raymond C. Kubacki | Director, Chairman, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 23,000 | 237,374 (4%) | 0% | 0 | Common Stock, $.005 Par Value |